RecruitingPhase 2NCT06887062

Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV)

Studying Giant cell arteritis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Edinburgh
Intervention
Bosentan and dapagliflozin(drug)
Enrollment
60 enrolled
Eligibility
18 years · All sexes
Timeline
20252027

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06887062 on ClinicalTrials.gov

Other trials for Giant cell arteritis

Additional recruiting or active studies for the same condition.

See all trials for Giant cell arteritis

← Back to all trials